Published By Robert J. Szczerba in forbes.com
Brain training is the use of a brain-computer interface to learn to treat the dysfunctional networks and re-regulate cognitive and mental functioning.
More than 20% of Americans regularly consume prescribed drugs related to mental health issues, earning contemporary America the nickname, “the Prozac Generation.” However, developing safe, targeted, and effective drugs for mental illnesses has increasingly become a struggle for the pharmaceutical industry. As a result, there’s been a gradual withdrawal of research dollars from this area, despite the fact that globally, the mental health pharmaceutical market is more than $80 billion.
Call or Text us for an Introductory NeuroFeedback Session in Our Kitsilano, Vancouver, BC Location. 604-785-1709 www.no-stress-success.com
According to the National Institute for Mental Health (NIMH), more than 57 million people, or 26% of the U.S. population suffer from some form of mental health problem. But despite the ongoing need, one can legitimately claim that research has not produced a novel neurological drug in the past 30 years. Additionally, many drugs currently on the market have been increasingly identified with negative side effects and limited efficacy.
Read More: http://www.forbes.com/sites/robertszczerba/2014/03/04/brain-training-and-the-end-of-the-prozac-generation-2/